期刊文献+

移植后地西他滨输注治疗儿童难治性急性髓系白血病合并神经母细胞瘤1例 被引量:1

下载PDF
导出
摘要 1病例资料1.1移植前诊治经过患儿,男,3岁4月,2017年6月因面色苍白、乏力1月入院,查体:贫血貌,右颌下及双侧腹股沟可及数枚黄豆大小肿大淋巴结,心肺未见异常,肝脾未及。实验室检查:血常规:白细胞52.71×10^(9)/L、淋巴细胞30.7%、血红蛋白45g/L、血小板35×10^(9)/L;骨髓象:原始细胞占42%;白血病免疫分型:分析幼稚群体58.9%,CD3377.5%,CD11b 58.3%,CD45100%,CD1562.9%,CD6463.7%,HLA-DR 39.8%,MPO 74%。
作者 钟志娟 卢俊
出处 《中国小儿血液与肿瘤杂志》 CAS 2021年第1期45-47,共3页 Journal of China Pediatric Blood and Cancer
  • 相关文献

参考文献5

二级参考文献41

  • 1Howlader N, Noone AM, Krapcho M, et al, eds. SEER statistics review, 1975-2009 ( Vintage 2009 Populations)[M]. Bethesda, Md: National Cancer Institute, 2012.
  • 2Homer M J, Ries LA, Krapcho M, et al. SEER cancer statistics review, 1975-2006[M]. Bethesda, Md: National Cancer Institute, 2009.
  • 3Brodeur GM, Pritchard J, Berthold F, et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, andresponse to treatment[J]. J Clin Oncol, 1993, 11 (8): 1466- 1477.
  • 4Shimada H,Ambros IM, Dehner LP, et al. The Ivtemational Neuroblastoma Pathology Classification (the Shimada system) [J]. Cancer,1999,86 (2) : 364-372.
  • 5Peuchmaur M Amore ES, Joshi VV, et al. Revision of the International Neuroblastoma Pathology Classification: confirmation of favorable and unfavorable prognostic subsets in ganglioneuroblastoma, nodular [J ]. Cancer, 2003, 98 (10) : 2274-2281.
  • 6Monclair T, Brodeur GM, Ambros PF, et al. The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report [J]. J Clin Oncol , 2009, 27 (2): 298-303.
  • 7Brisse HJ,McCarville MB, Granata C, et al. Guidelines for imaging and staging of neuroblastic tumors: consensus report from the International Neuroblastoma Risk Group Project[D]. Radiology, 2011, 261 (1) : 243-257.
  • 8Brodeur GM,Pritchard J, Berthold F, et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment[J]. J Clin Oncol, 1993,11 (8) : 1466- 1477.
  • 9Strother DR,London WB, Schmidt ML, et al. Outcome after surgery alone or with restricted use of chemotherapy for patients with low-risk neuroblastoma: results of Children's Oncology Group study P9641[J]. J Clin Oncol , 2012, 30 (15) : 1842-1848.
  • 10Baker DL, Schmidt ML, Cohn SL, et al. Outcome after reduced chemotherapy for intermediate-risk neuroblastoma[J]. N Engl J Med, 2010,363 (14): 1313-1323.

共引文献221

同被引文献17

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部